Artelo Biosciences
$1.529876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.06 (-3.80%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell ARTL and other stocks, options, and ETFs commission-free!
About ARTL
Artelo Biosciences, Inc. Common Stock, also called Artelo Biosciences, is a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system.
CEO
Gregory D. Gorgas
Employees
3
Headquarters
San Diego, California
Founded
2011
Market Cap
24.34M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
646.98K
High Today
$1.57
Low Today
$1.50
Open Price
$1.54
Volume
390.98K
52 Week High
$3.67
52 Week Low
$0.451
ARTL Earnings
-$0.42
-$0.28
-$0.14
-$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Apr 20, Pre-Market